Skip to content

Drug interactions

Bosutinib + Pazopanib

Severity: Moderate

Bosutinib and Pazopanib: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Bosutinib inhibits P-glycoprotein and may increase pazopanib exposure. Both drugs are also associated with hepatotoxicity and QT effects, adding to the concern.

What this interaction means in plain words

Bosutinib and Pazopanib can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Bosutinib belongs to Oncology; Pazopanib belongs to Oncology.

Evidence level: Low

Why it happens

P-gp inhibition by bosutinib increases pazopanib bioavailability, with overlapping hepatotoxic effects.

What to do

Monitor liver function tests regularly and consider ECG monitoring. Reduce the dose of either drug if transaminases rise.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Bosutinib and Pazopanib, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Bosutinib with Pazopanib?

MediHelp rates the interaction as moderate. Bosutinib and Pazopanib can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Bosutinib inhibits P-glycoprotein and may increase pazopanib exposure. Both drugs are also associated with hepatotoxicity and QT effects, adding to the concern.

How serious is the interaction between Bosutinib and Pazopanib?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor liver function tests regularly and consider ECG monitoring. Reduce the dose of either drug if transaminases rise.

What other medicines interact with Pazopanib?

MediHelp also lists interactions of Pazopanib with, for example, Adagrasib, Amiodarone, Amisulpride. The full list is on the Pazopanib page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in